the changing standard of care in dlbcl
Published 1 month ago • 69 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
2:53
autohct in dlbcl in the car-t era
-
7:16
changes in the classification of dlbcl
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
5:12
the current standard of care in advanced stage hl
-
3:04
applying molecular understanding of dlbcl to management strategies
-
1:45
improving the frontline treatment of dlbcl
-
2:00
the development of anti-fibrotic agents for treating myelofibrosis
-
2:03
novel treatment approaches for early-stage dlbcl
-
0:58
improving second-line treatments in dlbcl
-
0:42
targeted therapies for dlbcl treatment
-
1:33
zamtocabtagene autoleucel for the treatment of patients with r/r dlbcl
-
1:15
personalized medicine for dlbcl
-
1:53
the current immunotherapeutic landscape for treatment of dlbcl
-
3:21
safety management of car-t cell therapy in dlbcl
-
2:46
transform: liso-cel versus standard of care as second-line therapy for r/r lbcl
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
3:05
car-t therapy in r/r dlbcl
-
3:02
new technologies informing soc in dlbcl